InFibrosis Early Inflammation in Fibrotic Niches of Chonic Kidney Disease
- Coordinator
- Universite Paris Cite, France
- Runs
- 1 January 2027 to 31 December 2031
- Status
- Running
- EU funding
- €1.5m
- Total cost
- €1.5m
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101302838
What the project is doing
In the project's own words, from its summary on CORDIS.
Chronic kidney disease (CKD) affects more than 10% of the global population and remains a major unmet medical challenge. Fibrosis, the hallmark of CKD, develops in spatially restricted microenvironments known as fibrogenic niches, where immune and stromal cells engage in reciprocal communication that sustains myofibroblast activation and progressive tissue scarring. However, the early inflammatory events that initiate these niches—particularly the dialogue between macrophages and fibroblasts—remain poorly understood.
InFibrosis aims to decipher how inflammation triggers fibrogenic niche formation in the kidney. The project combines human biopsy cohorts, spatial analysis, and innovative experimental systems to link molecular mechanisms with disease prognosis. Specifically, I will (i) develop histology-based prognostic markers identifying inflammatory zones predictive of CKD progression; (ii) dissect macrophage–stromal crosstalk driving fibroblast activation using advanced in vitro techniques and single-cell analyses, including the first human “niche-in-a-dish” model that reproduces the inflammatory microenvironment leading to fibrosis; and (iii) identify and functionally test druggable pathways capable of disrupting these pathogenic circuits.
By integrating clinical, histological, and mechanistic approaches, InFibrosis will redefine our understanding of how inflammation shapes fibrosis in early CKD. The expected outcomes include predictive tools for patient stratification and novel therapeutic targets that pave the way toward interventions modulating cell–cell communication to prevent chronic kidney disease progression.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universite Paris Cite | Paris | France | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI